You track your resting heart rate, your VO2 estimate, your morning HRV. If you're starting testosterone therapy, add one more device to the counter: a home blood pressure cuff. It's cheap, it's boring, and it may be the most useful number you watch in your first weeks on protocol.

Why blood pressure deserves a seat at the table

Most conversations about testosterone therapy (TRT) orbit two labs: estradiol and PSA. Those matter. But blood pressure is a signal you can read at home, and it's one the U.S. Food and Drug Administration has flagged directly. In 2025 the FDA updated the labeling for testosterone products to add a warning that they can increase blood pressure, which can raise the risk of cardiovascular events [1]. That's not a reason to avoid therapy — it's a reason to measure.

Here's the thing an optimizer appreciates: blood pressure isn't a mystery variable. On TRT it tends to move for reasons you can actually name and monitor. Understanding the mechanism turns "watch your BP" from a vague warning into a specific, trackable dashboard.

The mechanism: hematocrit, fluid, and pressure

Testosterone stimulates the bone marrow and the kidney's production of erythropoietin, which increases red blood cell production. The result shows up on your complete blood count as a rising hematocrit — the percentage of your blood volume made up of red cells. Erythrocytosis (an elevated hematocrit) is one of the most common findings in men on testosterone therapy, and the Endocrine Society's clinical practice guideline specifically recommends monitoring hematocrit before and during treatment [2].

Why does a busy exec care about a red-cell number? Because thicker, more viscous blood is harder to push through your vessels. As hematocrit climbs, blood viscosity rises, and that can nudge blood pressure and cardiovascular load upward. Testosterone can also affect sodium and fluid handling, contributing to mild fluid retention early in therapy. Blood pressure is the downstream number where several of these threads meet — which is exactly why it's worth reading at home from week one, long before your next blood draw.

Two Numbers Worth Watching
2025FDA labeling updateClass warning added: testosterone can raise blood pressure
HematocritGuideline monitoringEndocrine Society recommends checking before and during therapy
<120Normal systolicmm Hg, per ACC/AHA

Source: [1] FDA requires new class warning about blood pressure increase for testosterone products, [2] Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline

What "elevated" actually means

If you're going to track a number, know the goalposts. The American College of Cardiology and American Heart Association define the categories clearly [3]:

  • Normal: less than 120 / less than 80 mm Hg
  • Elevated: 120–129 / less than 80
  • Stage 1 hypertension: 130–139 or 80–89
  • Stage 2 hypertension: 140+ or 90+

These categories are based on a proper average of readings, not a single anxious measurement after coffee and a red-eye flight. Technique matters: back supported, feet flat, arm at heart level, no caffeine or exercise in the 30 minutes prior, and an average of two readings on separate occasions [3]. A dialed-in optimizer treats a home cuff like any other instrument — controlled conditions produce a signal you can trust.

Blood Pressure Categories (ACC/AHA)
Normal 120Elevated 130Stage 1 140Stage 2 160

mm Hg (systolic) · marker = Stage 1 begins

Source: [3] 2017 ACC/AHA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults

Home cuff vs. the lab: two different jobs

Think of it as two monitoring loops running at different frequencies.

Your home cuff is the high-frequency loop. It's the day-to-day trend line that can flag a drift weeks before a scheduled panel. If you're the kind of person who logs everything, a simple weekly average is enough to show a provider a real pattern rather than a one-off spike.

Your labs are the lower-frequency, deeper loop. Beyond estradiol and PSA, an independent provider reviewing testosterone therapy typically looks at hematocrit and hemoglobin on a complete blood count to catch erythrocytosis, alongside a lipid panel and the broader metabolic picture [2]. The blood pressure trend and the hematocrit trend are read together — because as we covered, they're mechanistically linked. A rising cuff reading and a rising hematocrit tell a more complete story than either alone.

This is where responsive management earns its keep. A protocol isn't set once a year and forgotten. A provider may adjust based on how these numbers move — the exact opposite of the shrug-and-recheck-in-twelve-months experience that leaves so many men frustrated. The point of tracking from week one is to give an independent provider real data to act on, promptly.

For the guy who's still deciding

If your labs have confirmed genuinely low testosterone and you've been told to "just lose the weight," the blood pressure conversation can feel like one more reason to hesitate. Reframe it. A home cuff isn't a hurdle — it's how safe therapy is supposed to work. Monitoring is the feature, not the friction. You don't need to fear a number you're actively watching with a provider who reviews it.

And no, tracking blood pressure isn't about self-diagnosing or self-adjusting anything. Dosing, formulation, and any changes to a plan are decided by an independent licensed provider — not by an app, a forum, or a spreadsheet. Your job is to measure well and report honestly.

Beyond the cuff: the rest of the picture

Blood pressure is one instrument on a wider panel. A thorough review of testosterone therapy considers hematocrit, estradiol, PSA, lipids, and symptoms together — because hormone optimization is a system, not a single dial. Estrogen balance, in particular, is part of the male picture and is managed alongside testosterone rather than ignored. The value of monitoring several signals is that it lets a provider fine-tune with context instead of guessing.

Some men are prescribed FDA-approved testosterone products; others may be candidates for compounded formulations depending on the clinical situation and state rules. Compounded medications are not reviewed or approved by the FDA for safety, effectiveness, or quality. Compounded products are not equivalent to or interchangeable with any FDA-approved brand-name drug. Availability varies by state. Whether any medication is appropriate — and which one — is always a decision made by an independent licensed provider. A prescription is never guaranteed.

*This article is educational and is not medical advice, diagnosis, or a recommendation to take any specific medication. Talk with a licensed provider about your individual situation.*

Where Velri fits

Velri is a technology and coordination company — not a medical practice. We help coordinate the pieces that make monitoring actually happen: lab work through independent labs, a visit with an independent, licensed provider who reviews your full picture, and — if a provider decides a prescription is appropriate — fulfillment through an independent, licensed pharmacy. The clinical decisions, including whether therapy makes sense and how it's managed over time, belong to the provider. Our role is to keep the loop tight so the number on your cuff, and the numbers in your labs, get seen by someone who can act on them.